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ABSTRACT
Obesity is characterized with excessive accumulation of the body fat which occurs when 
the energy intake exceeds the expenditure. It is routinely associated with insulin resistance 
and hyperinsulinemia. Additionally, suppressing insulin level protects female mice from 
weight gaining. Cinnamon [Cinnamomum burmannii (Ness) Bl. Cortex] suppresses 
hyperinsulinemia condition in the type 2 diabetic rat suggesting the possible beneficial its 
role in the obesity. We aimed to investigate the effect of Cinnamon extract in the normal 
obese subjects. In this preliminary cross-over clinical trial, 24 normal obese subjects were 
recruited and divided randomly into two groups i.e. treatment and placebo. Two grams 
of the cinnamon extract were given twice daily for 56 days in the treatment group. 
Normal obese subjects given placebo were allocated as the placebo group. After the 
treatment, each of the group ran a one month run-in period, then the groups were cross-
overed for the next 56 days. Body mass index (BMI), insulin serum level, cholesterol and 
triglyceride plasma levels were measured at the beginning and at the end of the study. 
No diet restriction nor exercise intervention was given during the study. At the end of the 
study, BMI in the treatment group (58%) were slightly reduced when compared to the 
placebo group (33%), however, it was not significantly different (p>0.05). Moreover, 
significantly reduction in the insulin serum level was observed in 63% subject in the 
treatment group compared to 33% subject in the placebo group (p < 0.05). Additionally, 
there were no significant differences of cholesterol and triglyceride plasma level observed 
in the both group. In conclusion, cinnamon extract may give beneficial role in the normal 
obese subjects by suppressing the serum insulin level. Further studies are required to 
elucidate the specific role of cinnamon in preventing weight gain. 
ABSTRAK
Kegemukan ditandai dengan akumulasi berlebhan lemak tubuh yang terjadi ketika 
pemasukan energi melebihi pengeluaran. Kegemukan sering dikaitkan dengan resistensi 
insulin dan hiperinsulinemia. Selain itu terbukti penurunan kadar insulin mencegah 
kegemukan pada mencit. Kayu manis [Cinnamomun burmannii (Ness) BI. Cortex] dapat 
menekan kondisi hyperinsulinemia pada tikus diabetes tipe 2 dan diduga bermanfaat 
dalam mencegah kegemukan. Penelitian ini bertujuan untuk mengkaji efek ekstrak kayu 
putih pada sukarelawan sehat. Pada uji klinik awal dengan rancangan silang ini, 24 
sukarelawan dengan kegemukan normal yang dilibatkan penelitian dibagi acak menjadi dua 
kelompok yaitu kelompok perlakuan dan kontrol. Dua gram ekstrak kayu putih diberikan 
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dua kali sehari selama 56 hari pada kelompok perlakuan, sedangkan kelompok kontrol 
diberi plasebo. Setelah perlakuan, masing-masing kelompok diberi latihan (lari) setiap 
hari selama satu bulan, kemudian masing-masing kelompok disilang untuk mendapatkan 
perlakuan atau kontrol selama 56 hari berikutnya. Indeks massa tubuh (IMT), kadar insulin 
serum, kadar kolesterol dan trigliserit plasma diukur di awal dan akhir penelitian. Tidak 
ada pembatasan dan juga latihan diberikan selama penelitian. Di akhir penelitian, IMT 
kelompok perlakuan (58%) sedikit turun dibandingkan kelompok plasebo (33%). Namun 
demikian perbedaan ini tidak bermakna (p>0,05). Selanjutnya, penurunan kadar insulin 
serum secara nyata terjadi pada 63% sukarelawan pada kelompok perlakuan dibandingkan 
33% pada kelompok plasebo (p<0,05). Tidak ada perbedaan nyata kadar kolesterol 
dan trigliserida plasma antara kedua kelompok. Dapat disimpulkan, ekstrak kayu manis 
bermanfaat bagi subjek dengan kegemukan normal melalui perannya dalam menurunkan 
kadar insulin serum. Penelitian lanjutan diperlukan untuk mengkaji peran spesifik kayu 
manis dalam mencegah kegemukan. 
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INTRODUCTION
Obesity is a metabolic disorder 
characterized with excessive expansion of 
adipose tissue due to imbalances between 
nutrient intake and energetic activity.1 Obesity 
has remarkably increased worldwide and 
leads to significant morbidity and mortality 
related to cardiovascular disease, metabolic 
syndrome, type 2 diabetes, hypertension, 
degenerative joint disease and some kinds 
of cancer. It is affecting 33% of adults in the 
United States and becomes the most common 
public health problems.2 Some strategies 
have been proposed to reduce enormous body 
weight in the obese state by inhibiting fat 
absorption in the gut or supressing appetite 
in the brain. Recently, it is found that insulin 
resistance and hyperinsulinemia are the key 
characteristics of obesity which contributes 
to its further complication on health.3-5 In 
the obese state, compensatory rise of insulin 
due to hyperglycemia, may lead to insulin 
resistance.6 Furthermore, hyperinsulinemia 
may promote obesity, resulting in a vicious 
cycle between obesity, insulin resistance and 
hyperinsulinemia.6-11 It has been reported 
that attenuating hyperinsulinemia in the 
experimental young female mice provides 
protection against obesity and reducing 
insulin secretion may promote weight loss in 
obese adults with insulin hypersecretion.6,12,13 
Conclusively, reducing insulin secretion may 
have beneficial role in the strategy of obesity 
treatment.
Cinnamomum burmannii (Ness) BI. 
Cortex, widely known in Indonesia as 
cinnamon or kayu manis, cassia in Padang 
and Batavia, is an endogenous plant that 
has been traditionally used as spices, herb 
and medicine.14 It is currently marketed as 
a supplemental herbal for diabetes mellitus, 
dyslipidaemia and glucose intolerance since 
experimental. Clinical evidence showed that 
cinnamon has a role as insulin sensitizing 
agent. In 3T3L1 adipocyte tissue, cinnamon 
extract stimulates glucose uptake and glycogen 
synthesis and further activates glycogen 
synthase.15 Additionally, cinnamon bioactive 
component stimulates enzymatic reaction 
of phosphorylation and dephosphorylation, 
confirming its role as an insulin mimetic.16 
Furthermore, cinnamon extract may decrease 
the blood glucose level and stimulate glucose 
uptake in the experimental type 1 diabetic 
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rat or type 2 diabetic mice.17-20 Recently, 
evidences have been reported that cinnamon 
bioactive components, proanthocyanidin and 
cinnamaldehyde, could improve the formation 
of pancreatic islet polypeptide and suppress 
hyperinsulinemia condition in the type 2 
diabetic rat.21-23
In the clinical setting, daily consumption 
of 1, 3 or 6 g cinnamon supplement reduced 
the blood glucose level up to 29% in the type 
2 diabetic patients24 and routine consumption 
of 3 g cinnamon supplement in eight weeks 
reduced body weight and body mass index 
(BMI) in type 2 diabetic patients.25 These 
mechanisms may be mediated through the 
role of cinnamon in improving the body 
composition and attenuating lipogenic 
processes in the liver and adipose tissue.26 
Conversely, another study reported that 4 
month treatment with a dietary supplement 
containing cinnamon, chromium and carnosine 
decreased fasting plasma glucose (FPG) and 
increased fat-free mass. However, there was 
no different with placebo with respect to body 
weight and BMI in overweight or obese pre-
diabetic subjects.27 Despite our significant 
understanding of the role of cinnamon in 
the improvement of diabetes, the roles of 
cinnamon in obesity and its insulin regulation 
are largely unknown. In the present study, we 
investigated the effect of cinnamon extract in 
the normal obese subjects.
MATERIALS AND METHODS
Cinnamon burmannii extract
Cinnamon extract was prepared in a 
capsules preparation by UD Rachma Sari 
and certified by the National Agency of Drug 
and Food Control, Republic of Indonesia 
(TR 123365801). Each cinnamon capsules 
contained two g of cinnamon extract. Placebo 
capsules were packaged as the same as the 
cinnamon capsule. Both the cinnamon and 
placebo capsules were packaged in plastic 
bag containing 14 capsules (two capsules of 
two g for 7 days) and prepared for distribution 
of the subjects. Subjects received one capsule 
twice daily (with the total dose of 4 g/day) 
for 56 days. The dose were decided based on 
two previous studies using dose range from 1 
– 6 g/day.24,25 Subjects were evaluated every 
7 days for supplement compliance until the 
end of the study. Compliance was monitored 
by capsule count, subjects interview and daily 
diary analysis.
Design
The design of this preliminary study was 
randomized cross-over clinical trial study. 
The study was divided in two phase, in each 
of the phase every subject received 56 days of 
capsules (treatment or placebo). Subjects were 
recruited and allocated randomly into two 
groups i.e. treatment and placebo. Cinnamon 
capsules were given for 56 days in normal 
obese subjects in the treatment group. Another 
group of normal obese subjects were given 
placebo as the placebo group. After finishing 
56 days treatment, each of the group ran a one 
month run-in period, and then the groups were 
cross-overed for the next 56 days. Subjects 
were not informed which treatment they have 
received until the end of the study. 
Study population
This study was conducted in the Faculty 
of Medicine and Health Science, Islamic State 
University and was approved by the Ethics 
Committee and Human Studies Review Board 
of Faculty of Medicine and Health Science, 
Islamic State University. Selection criteria for 
the study were adult normal obese subjects 
with BMI ≥ 23 kg/m2 and age ranged from 
18 to 70 year old. Subjects were excluded 
from the study if they have: degenerative 
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disease (hypertension, diabetes mellitus, 
coronary artery disease, atherosclerosis), 
cancer, scheduled diet process, pregnancy, 
breastfeeding, long term pharmacotherapy 
(chemotherapy, corticosteroid, insuling 
sensitizing agent, anti-hypertension and anti-
cholesterol). 
Follow up and outcome measures
Body mass index were measured by 
dividing body weight (kg) with squared of 
body height (m). The serum insulin level was 
measured by ELISA technique using ELISA 
insulin kit (Calbiotech, Spring Valley, CA, 
USA). In brief, subjects sera were incubated 
for 60 minutes with insulin enzyme conjugate, 
washed, added with TMB substrat for 15 
min. After the addition of stop solution, sera 
were analyzed by ELISA reader. The plasma 
cholesterol level was measured by cholesterol 
esterase/cholesterol oxidase technique 
using cholesterol kit (Sclavo Diagnostics, 
Siena, Italy). The plasma triglyceride level 
was measured by triglyceride kit (Diasys 
Diagnostic System, Holzheim, Germany). 
Subjects were followed up every 7 days, 
however, outcome measures were conducted 
only on day 1 and day 56. At each visits, the 
occurrence of study outcomes was ascertained 
according to the intention-to-treat principle.
Data analysis 
The variable of this study were the BMI, 
the serum insulin level, the plasma cholesterol 
and tryglyceride levels. All variable data 
from the recruited patients were included in 
the analyses. Comparison among groups was 
performed using one-way analysis of variance 
(ANOVA) or student’s t-test, wherever 
applicable. A p <0.05 was considered as 
statistically significant.
RESULTS
Baseline characteristics
The characteristics of subjects were 
summarized in TABLE 1. Twenty four normal 
obese subjects were recruited and followed up 
every 7 days until the end of the study. None 
of them were dropped out during the study. No 
significant differences of BMI, insulin serum 
level, cholesterol plasma level and triglyceride 
plasma level were observed among the groups 
(p > 0.05).
TABLE 1. Baseline characteristics (mean ± SD) between placebo and treatment group 
Variablle Placebo group n=24
Treatment group 
n=24 p
Male 
Female
Body Mass Index (kg/m2)
Insulin (mg/dL)
Cholesterol (mg/dL)
Triglyceride (mg/dL)
12
12
28.9 ± 4.8
23.6 ± 22.2
164 ± 41
121 ± 70
12
12
28.9 ± 5.0
19.4 ± 14.3
171 ± 27
111 ± 66
0.9
0.4
0.5
0.6
Effect of cinnamon on BMI and 
insulin serum level
The effect of cinnamon extract on the BMI 
and the serum insulin level were summarized 
in TABLE 2. There was no significantly 
different on the BMI observed between the 
placebo and the treatment group, however, 
slight decrease of 0.1 point was observed. 
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The serum insulin level increased 8.2 point, 
however, it was not significantly different. 
The serum insulin was decreased in 8 subjects 
received placebo (33%) and increased in the 
rest of the subjects. Conversely, cinnamon 
extract decreased the serum insulin level in 
15 subjects (63%). Briefly, the serum insulin 
TABLE 2.  Effect of cinnamon extract on BMI, serum insulin level, plasma cholesterol and triglyceride levels after 
56 days of treatment
Variable
Placebo Treatment
p
Day 1 Day 56 Day 1 Day 56
Body Mass Index (kg/m2) 
Insulin (mg/dL) 
Cholesterol (mg/dL) 
Triglyceride (mg/dL)
28.9 ± 4.8
23.6 ± 22.2
164 ± 41
121 ± 70
28.9 ± 4.9
31.8 ± 27.3
169 ± 18
135 ± 84
28.9 ± 5.0
19.4 ± 14.3
171 ± 27
111 ± 66
28.8 ± 4.7
16.6 ± 16.4
165 ± 14
109 ± 76
0.94
0.02
0.47
0.26
level was significantly higher on day 1 (19.4 
± 14.3 mg/dL) than on day 56 (16.6 ± 16.4 
mg/dL) in the treatment group (p<0.05). No 
significantly different in plasma cholesterol 
and triglyceride levels of the both group on 
day 1 and on day 56 were observed (p > 0.05).
DISCUSSION
The salient finding of our research are: 
(1) cinnamon extract decreased the level 
of insulin serum in 63% subjects and (2) 
cinnamon extract decreased significantly the 
level of insulin serum in 56 days compared 
to the placebo. In the obese state, insulin 
may elevate as a compensatory mechanism 
due to chronic hyperglycemia. Additionally, 
the chronic elevation of insulin serum level 
may decrease the insulin responsiveness in 
the tissues and lead to insulin resistance.6 
Chronic hyperglycemia and hyperinsulinemia 
work reciprocally and worsen the obese state, 
resulting in a vicious cycle between obesity, 
insulin resistance and hyperinsulinemia.6-11 
Clinical and experimental evidence have 
shown that attenuating hyperinsulinemia not 
only promote weight loss but also provide 
protection against obesity.6,12,13
Cinnamon has been widely used as 
spices, herb and traditional medicine. It has 
been reported that cinnamon exerts potent 
anti-diabetic effects through its role as insulin 
mimetic and insulin sensitisizing agent.15-20 
Moreover, cinnamon gives beneficial role 
in the type 2 diabetic patient by reducing 
significantly plasma blood glucose level.24,25 
We have shown in this study that cinnamon 
extract decreased the level of insulin serum in 
63% normal obese subjects and it decreased 
significantly the level of insulin serum in 56 
days of study. Our results were consistent with 
the previous finding that cinnamon component 
of proanthocyanidin improves the formation 
of pancreatic islet polypeptide and its 
cinnamaldehyde suppresses hyperinsulinemia 
condition.21-23 
Additionally, cinnamon extract decreased 
the BMI of the subjects, however, it was 
not significantly different. Previous study 
has shown that routine consumption of 3 g 
cinnamon supplement in eight weeks reduced 
body weight and BMI in type 2 diabetic 
patient.25 These mechanisms may be mediated 
through the role of cinnamon in improving the 
body composition and attenuating lipogenic 
processes in the liver and adipose tissue.26 
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Another study reported that 4 month treatment 
with a dietary supplement containing 
cinnamon, chromium and carnosine 
decreased fasting plasma glucose (FPG) and 
increased fat-free mass, however, there was 
no difference versus placebo with respect to 
body weight and BMI in overweight or obese 
pre-diabetic subjects.27 We have concluded 
that negative result of cinnamon on the BMI 
in our study may be due to differences in the 
dose regiment and duration. We should give 
the proper regiment with longer treatment to 
evaluate the long-term effect of cinnamon in 
preventing the weight gain. 
Some strategies have been proposed to 
reduce excessive body weight in the obese 
state by inhibiting fat absorption in the 
gut or suppressing appetite in the brain.2 
Recently, it is found that insulin resistance and 
hyperinsulinemia are the key characteristics 
of obesity which contributes to its further 
complication on health.3-5 Consistent with 
the previous finding, we have shown that 
cinnamon may give beneficial role in obesity 
not only by increasing insulin sensitivity 
but also by attenuating hyperinsulinemia 
condition.
CONCLUSIONS
Cinnamon extract may give beneficial role 
in the normal obese subjects by suppressing 
the serum insulin level. Further studies are 
required to elucidate the specific role of 
cinnamon in preventing weight gain.
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